US Market News
1月前
CORRECTING and REPLACING Xylem Reports First Quarter ResultsApril 28, 2026 10:27 AM
Business Wire
First-Quarter Highlights
Orders of $2.2 billion, up 3% on a reported basis and flat organically
Revenue of $2.1 billion, up 3% on a reported basis and flat organically
Earnings per share of $0.79, up 14%; $1.12 on an adjusted basis, up 9%
In the Xylem Inc. Non-GAAP Reconciliation Reported vs. Organic Revenue table, the last column in the fourth row, Measurement and Control Solutions, should read 1% (instead of (1%)).
The updated release reads:
XYLEM REPORTS FIRST QUARTER RESULTS
First-Quarter Highlights
Orders of $2.2 billion, up 3% on a reported basis and flat organically
Revenue of $2.1 billion, up 3% on a reported basis and flat organically
Earnings per share of $0.79, up 14%; $1.12 on an adjusted basis, up 9%
Xylem Inc. (NYSE: XYL), a leading global water solutions company dedicated to solving the world’s most challenging water issues, today reported first-quarter 2026 results. The Company delivered total revenue of $2.1 billion, on strong execution. First-quarter earnings per share were up 14 percent on a reported basis and 9 percent on an adjusted basis.
“We entered the year with sustained momentum and solid demand across key end markets,” said Matthew Pine, Xylem’s CEO. “While the external environment remains dynamic, our teams are executing well, staying close to customers, and advancing long-term priorities.” Pine added, “Our steady progress this quarter demonstrates that our multi-year operating transformation is gaining traction, with disciplined execution and operational rigor.”
Net income attributable to Xylem for the quarter was $193 million, or $0.79 per share. Net income margin increased 90 basis points to 9.1 percent. These results are driven by strong operational performance and a reduction in the estimated loss on sale of businesses, partially offset by increased restructuring and realignment costs. Adjusted net income attributable to Xylem was $272 million, or $1.12 per share, which excludes the loss on sale of businesses, purchase accounting intangible amortization, restructuring and realignment costs, and special charges.
First-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 20.6 percent, reflecting a year-over-year increase of 20 basis points. Productivity savings and strong price realization drove the margin expansion, exceeding the impact of inflation, mix, and lower volumes.
Outlook
Xylem now forecasts full-year 2026 revenue of approximately $9.2 to $9.3 billion, up approximately 2 to 3 percent on a reported basis, versus 1 to 3 percent previously guided, and up approximately 2 to 4 percent on an organic basis, as previously guided.
Full-year 2026 adjusted EBITDA margin is expected to be approximately 22.9 to 23.3 percent, an increase of 70 to 110 basis points from Xylem’s 2025 adjusted results. This results in full-year adjusted earnings per share of $5.35 to $5.60, in line with the previous guidance range. Full-year free cash flow margin is still expected to be approximately 10.2 to 11.0 percent.
Further 2026 planning assumptions are included in Xylem’s first-quarter 2026 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.
Supplemental information on Xylem’s first-quarter earnings, as well as definitions of and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.
About Xylem
Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 22,000 employees delivered revenue of $9 billion in 2025, optimizing water and resource management with innovation and expertise. Join us at www.xylem.com and Let’s Solve Water.
Xylem uses our Investor Relations website, www.xylem.com/en-us/investors, as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts, and social media.
Forward-Looking Statements
This press release contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “goal,” “objective,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.
Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, interest rates, availability of funding for our customers, inflation and governments’ related monetary policy in response, and the strength of the real estate markets, on economic activity and our operations; geopolitical matters, including nationalism, protectionism and anti-global sentiment, volatility involving the U.S. and other governments, ongoing, escalation or outbreak of international conflicts, and regulatory, trade protection, economic and other risks associated with our global sales and operations; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, labor shortages, trade agreements, tariffs, and other trade protection measures, and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents, data breaches, or other disruptions of information technology systems on which we or our customers rely, or involving our connected products and services; lack of availability or delays in receiving parts and raw materials from our supply chain, including semiconductors or other key components; operational disruptions at our facilities or that of third parties upon which we rely; safe and compliant treatment and handling of water, wastewater and hazardous materials; failure to successfully execute large projects, including as respects performance guarantees and customers’ budgets, timelines and safety requirements; our ability to retain, compete for and attract leadership, other key talent and labor; defects, security, warranty and liability claims, and recalls related to our products; uncertainty around productivity, simplification, restructuring and realignment actions and related costs and savings; our ability to execute strategic investments for growth, including acquisitions and divestitures; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on our business and operations due to weather conditions, volatile weather events, or changing climate patterns; risks related to our sustainability efforts and related disclosures; fluctuations in foreign currency exchange rates; difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; failure to comply with, or changes in, laws or regulations, pertaining to our business conduct, operations, products and services, including anti-corruption, artificial intelligence, data privacy and security, trade, competition, the environment, and health and safety; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; matters related to intellectual property infringement or expiration of rights; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).
Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors, to our business, operating results, financial condition, outlook, or strategy, to our impacts on sustainability matters or other parties, or are required to be disclosed in our filings with the SEC or other regulatory authorities, and are not intended to create legal rights or obligations. In addition, historical, current, and forward-looking social, environmental and sustainability-related statements may be based on: standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future.
All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)
For the three months ended March 31,
2026
2025
Revenue from products
$
1,757
$
1,709
Revenue from services
368
360
Revenue
2,125
2,069
Cost of revenue from products
1,057
1,041
Cost of revenue from services
265
260
Cost of revenue
1,322
1,301
Gross profit
803
768
Selling, general and administrative expenses
472
460
Research and development expenses
56
56
Restructuring and asset impairment charges
31
21
Operating income
244
231
Interest expense
(4
)
(8
)
Other non-operating income, net
—
4
Gain/(Loss) on sale of businesses
4
(10
)
Income before taxes
244
217
Income tax expense
(55
)
(50
)
Net income
$
189
$
167
Net loss attributable to non-controlling interests
4
2
Net income attributable to Xylem
$
193
$
169
Earnings per share:
Basic
$
0.79
$
0.69
Diluted
$
0.79
$
0.69
Weighted average number of shares:
Basic
242.8
243.1
Diluted
243.4
243.8
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in millions)
March 31,
2026
December 31,
2025
ASSETS
Current assets:
Cash and cash equivalents
$
808
$
1,479
Receivables, less allowances for discounts, returns and credit losses of $53 and $68 in 2026 and 2025, respectively
1,796
1,759
Inventories
991
983
Prepaid and other current assets
243
244
Assets held for sale
192
176
Total current assets
4,030
4,641
Property, plant and equipment, net
1,151
1,159
Goodwill
8,292
8,332
Other intangible assets, net
2,213
2,272
Other non-current assets
1,268
1,230
Total assets
$
16,954
$
17,634
LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
969
$
1,013
Accrued and other current liabilities
1,182
1,237
Short-term borrowings and current maturities of long-term debt
531
534
Liabilities held for sale
73
72
Total current liabilities
2,755
2,856
Long-term debt
1,407
1,408
Accrued post-retirement benefit obligations
308
317
Deferred income tax liabilities
437
405
Other non-current accrued liabilities
818
899
Total liabilities
5,725
5,885
Redeemable non-controlling interest
249
258
Stockholders’ equity:
Common stock – par value $0.01 per share:
Authorized 750.0 shares, issued 260.3 shares and 259.9 shares in 2026 and 2025, respectively
3
3
Capital in excess of par value
8,772
8,759
Retained earnings
3,794
3,706
Treasury stock – at cost 21.2 shares and 16.3 shares in 2026 and 2025, respectively
(1,368
)
(768
)
Accumulated other comprehensive loss
(229
)
(220
)
Total stockholders’ equity
10,972
11,480
Non-controlling interests
8
11
Total equity
10,980
11,491
Total liabilities, redeemable non-controlling interest, and stockholders’ equity
$
16,954
$
17,634
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions)
For the three months ended March 31,
2026
2025
Operating Activities
Net income
$
189
$
169
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
65
68
Amortization
75
77
Share-based compensation
13
12
Restructuring and asset impairment charges
31
21
(Gain) Loss from sale of businesses
(4
)
10
Other, net
(8
)
11
Payments for restructuring
(37
)
(21
)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables
(58
)
(48
)
Changes in inventories
(18
)
(9
)
Changes in accounts payable
(61
)
(64
)
Changes in long term receivables
(31
)
(32
)
Other, net
(48
)
(161
)
Net Cash – Operating activities
108
33
Investing Activities
Capital expenditures
(90
)
(71
)
Acquisitions of businesses, net of cash acquired
—
(7
)
Proceeds from sale of businesses, net of cash disposed
—
48
Proceeds from the sale of property, plant and equipment
1
5
Cash paid for investments
—
(1
)
Cash paid for asset acquisition
(1
)
—
Cash received from cross-currency swaps
14
12
Other, net
—
(1
)
Net Cash – Investing activities
(76
)
(15
)
Financing Activities
Short-term debt issued, net
—
1
Long-term debt repaid
(4
)
(4
)
Repurchase of common stock
(563
)
(13
)
Proceeds from exercise of employee stock options
—
6
Dividends paid
(106
)
(98
)
Other, net
(10
)
(8
)
Net Cash – Financing activities
(683
)
(116
)
Effect of exchange rate changes on cash
(15
)
25
Increase in cash classified within assets held for sale
(5
)
—
Decrease in cash classified within assets held for sale
—
11
Changes in cash classified within assets held for sale
(5
)
11
Net change in cash and cash equivalents
(671
)
(62
)
Cash and cash equivalents at beginning of year
1,479
1,121
Cash and cash equivalents at end of period
$
808
$
1,059
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest
$
11
$
12
Income taxes (net of refunds received)
$
28
$
37
Xylem Inc. Non-GAAP Measures
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures that we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.
“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA Margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income attributable to Xylem and earnings per share attributable to Xylem, adjusted to exclude restructuring and realignment costs, amortization of acquired intangible assets, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt.
"Free Cash Flow Margin" defined as free cash flow, adjusted (as applicable) for significant cash paid or received for non-operational tax, acquisition or divestiture activities; divided by revenue.
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“Special charges" defined as non-recurring costs incurred by the Company, such as those related to acquisitions and integrations, divestitures and non-cash impairment charges.
“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic Orders ($ Millions)
(As Reported - GAAP)
(As Adjusted - Organic)
(A)
(B)
(C)
(D)
(E)
(F) = B+C+D+E
(G) = F/(A-D)
Change
% Change
Acquisitions
Divestitures
Change
% Change
Orders
Orders
2026 v. 2025
2026 v. 2025
Book-to-Bill
FX Impact
Adj. 2026 v. 2025
Adj. 2026 v. 2025
2026
2025
Quarter Ended March 31
Xylem Inc.
2,228
2,158
70
3
%
105
%
(12
)
5
(70
)
(7
)
0
%
Water Infrastructure
675
626
49
8
%
112
%
(8
)
5
(32
)
14
2
%
Applied Water
512
486
26
5
%
114
%
-
-
(15
)
11
2
%
Measurement and Control Solutions
475
402
73
18
%
94
%
-
-
(11
)
62
15
%
Water Solutions and Services
566
644
(78
)
(12
%)
100
%
(4
)
-
(12
)
(94
)
(15
%)
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic Revenue ($ Millions)
(As Reported - GAAP)
(As Adjusted - Organic)
(A)
(B)
(C)
(D)
(E)
(F) = B+C+D+E
(G) = F/(A-D)
Change
% Change
Acquisitions
Divestitures
Change
% Change
Revenue
Revenue
2026 v. 2025
2026 v. 2025
FX Impact
Adj. 2026 v. 2025
Adj. 2026 v. 2025
2026
2025
Quarter Ended March 31
Xylem Inc.
2,125
2,069
56
3
%
(5
)
5
(65
)
(9
)
0
%
Water Infrastructure
603
581
22
4
%
(3
)
5
(29
)
(5
)
(1
%)
Applied Water
448
435
13
3
%
-
-
(14
)
(1
)
0
%
Measurement and Control Solutions
508
490
18
4
%
-
-
(11
)
7
1
%
Water Solutions and Services
566
563
3
1
%
(2
)
-
(11
)
(10
)
(2
%)
Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
Q1 2026
Q1 2025
As Reported
Adjustments
Adjusted
As Reported
Adjustments
Adjusted
Total Revenue
2,125
-
2,125
2,069
-
2,069
Operating Income
244
98
a
342
231
94
a
325
Operating Margin
11.5
%
16.1
%
11.2
%
15.7
%
Interest Expense
(4
)
-
(4
)
(8
)
-
(8
)
Other Non-Operating Income (Expense)
-
5
b
5
4
-
4
Gain/(Loss) From Sale of Businesses
4
(4
)
c
-
(10
)
10
c
-
Income before Taxes
244
99
343
217
104
321
Provision for Income Taxes
(55
)
(20
)
d
(75
)
(50
)
(22
)
d
(72
)
Net Income
189
79
268
167
82
249
Net Loss Attributable to Non-controlling Interests
4
-
4
2
-
2
Net Income Attributable to Xylem
193
79
272
169
82
251
Diluted Shares
243.4
243.4
243.8
243.8
Diluted EPS
$
0.79
$
0.33
$
1.12
$
0.69
$
0.34
$
1.03
a
Restructuring & realignment costs: 2026 - $38 million; 2025 - $27 million
Special charges: 2026 - $5 million of acquisition, divestiture & integration costs; 2025 - $8 million of acquisition, divestiture & integration costs and $4 million of intangible asset impairment charges
Purchase accounting intangible amortization: 2026 - $55 million; 2025 - $55 million
b
Other special charges
c
Gain/(Loss) from sale of businesses as per income statement for all periods presented
d
2026 - Net tax impact on pre-tax adjustments (notes a, b and c) of $21 million and $1 million of other tax special expense items; 2025 - Net tax impact on pre-tax adjustments (note a and b) of $22 million
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
2026
Q1
Q2
Q3
Q4
Total
Net Income attributable to Xylem
193
193
Net Income margin
9.1
%
9.1
%
Depreciation
65
65
Amortization
75
75
Interest Expense (Income), net
(4
)
(4
)
Income Tax Expense
55
55
EBITDA
384
384
Share-based Compensation
13
13
Restructuring & Realignment
38
38
Special Charges
10
10
Loss/(Gain) from sale of businesses
(4
)
(4
)
Loss attributable to non-controlling interest
(4
)
(4
)
Adjusted EBITDA
437
437
Revenue
2,125
2,125
Adjusted EBITDA Margin
20.6
%
20.6
%
2025
Q1
Q2
Q3
Q4
Total
Net Income attributable to Xylem
169
226
227
335
957
Net Income margin
8.2
%
9.8
%
10.0
%
14.0
%
10.6
%
Depreciation
68
69
64
66
267
Amortization
77
76
78
77
308
Interest Expense (Income), net
-
3
-
(1
)
2
Income Tax Expense
50
75
71
35
231
EBITDA
364
449
440
512
1,765
Share-based Compensation
12
13
12
16
53
Restructuring & Realignment
27
29
30
45
131
Special Charges
12
13
9
2
36
Loss/(Gain) from sale of businesses
10
-
37
(16
)
31
Loss attributable to non-controlling interest
(2
)
(2
)
(1
)
(2
)
(7
)
Adjusted EBITDA
423
502
527
557
2,009
Revenue
2,069
2,301
2,268
2,397
9,035
Adjusted EBITDA Margin
20.4
%
21.8
%
23.2
%
23.2
%
22.2
%
View source version on businesswire.com: https://www.businesswire.com/news/home/20260427390392/en/
Media
Press Office
+1 (978) 704-5149
PressOffice@xylem.com
Investors
Michael Travers
+1 (724) 772-1597
Michael.Travers@xylem.com
Original: CORRECTING and REPLACING Xylem Reports First Quarter Results
US Market News
1月前
Xylem Reports First Quarter ResultsApril 28, 2026 6:55 AM
Business Wire
First-Quarter Highlights
Orders of $2.2 billion, up 3% on a reported basis and flat organically
Revenue of $2.1 billion, up 3% on a reported basis and flat organically
Earnings per share of $0.79, up 14%; $1.12 on an adjusted basis, up 9%
Xylem Inc. (NYSE: XYL), a leading global water solutions company dedicated to solving the world’s most challenging water issues, today reported first-quarter 2026 results. The Company delivered total revenue of $2.1 billion, on strong execution. First-quarter earnings per share were up 14 percent on a reported basis and 9 percent on an adjusted basis.
“We entered the year with sustained momentum and solid demand across key end markets,” said Matthew Pine, Xylem’s CEO. “While the external environment remains dynamic, our teams are executing well, staying close to customers, and advancing long-term priorities.” Pine added, “Our steady progress this quarter demonstrates that our multi-year operating transformation is gaining traction, with disciplined execution and operational rigor.”
Net income attributable to Xylem for the quarter was $193 million, or $0.79 per share. Net income margin increased 90 basis points to 9.1 percent. These results are driven by strong operational performance and a reduction in the estimated loss on sale of businesses, partially offset by increased restructuring and realignment costs. Adjusted net income attributable to Xylem was $272 million, or $1.12 per share, which excludes the loss on sale of businesses, purchase accounting intangible amortization, restructuring and realignment costs, and special charges.
First-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 20.6 percent, reflecting a year-over-year increase of 20 basis points. Productivity savings and strong price realization drove the margin expansion, exceeding the impact of inflation, mix, and lower volumes.
Outlook
Xylem now forecasts full-year 2026 revenue of approximately $9.2 to $9.3 billion, up approximately 2 to 3 percent on a reported basis, versus 1 to 3 percent previously guided, and up approximately 2 to 4 percent on an organic basis, as previously guided.
Full-year 2026 adjusted EBITDA margin is expected to be approximately 22.9 to 23.3 percent, an increase of 70 to 110 basis points from Xylem’s 2025 adjusted results. This results in full-year adjusted earnings per share of $5.35 to $5.60, in line with the previous guidance range. Full-year free cash flow margin is still expected to be approximately 10.2 to 11.0 percent.
Further 2026 planning assumptions are included in Xylem’s first-quarter 2026 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.
Supplemental information on Xylem’s first-quarter earnings, as well as definitions of and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.
About Xylem
Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 22,000 employees delivered revenue of $9 billion in 2025, optimizing water and resource management with innovation and expertise. Join us at www.xylem.com and Let’s Solve Water.
Xylem uses our Investor Relations website, www.xylem.com/en-us/investors, as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts, and social media.
Forward-Looking Statements
This press release contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “goal,” “objective,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.
Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, interest rates, availability of funding for our customers, inflation and governments’ related monetary policy in response, and the strength of the real estate markets, on economic activity and our operations; geopolitical matters, including nationalism, protectionism and anti-global sentiment, volatility involving the U.S. and other governments, ongoing, escalation or outbreak of international conflicts, and regulatory, trade protection, economic and other risks associated with our global sales and operations; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, labor shortages, trade agreements, tariffs, and other trade protection measures, and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents, data breaches, or other disruptions of information technology systems on which we or our customers rely, or involving our connected products and services; lack of availability or delays in receiving parts and raw materials from our supply chain, including semiconductors or other key components; operational disruptions at our facilities or that of third parties upon which we rely; safe and compliant treatment and handling of water, wastewater and hazardous materials; failure to successfully execute large projects, including as respects performance guarantees and customers’ budgets, timelines and safety requirements; our ability to retain, compete for and attract leadership, other key talent and labor; defects, security, warranty and liability claims, and recalls related to our products; uncertainty around productivity, simplification, restructuring and realignment actions and related costs and savings; our ability to execute strategic investments for growth, including acquisitions and divestitures; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on our business and operations due to weather conditions, volatile weather events, or changing climate patterns; risks related to our sustainability efforts and related disclosures; fluctuations in foreign currency exchange rates; difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; failure to comply with, or changes in, laws or regulations, pertaining to our business conduct, operations, products and services, including anti-corruption, artificial intelligence, data privacy and security, trade, competition, the environment, and health and safety; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; matters related to intellectual property infringement or expiration of rights; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).
Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors, to our business, operating results, financial condition, outlook, or strategy, to our impacts on sustainability matters or other parties, or are required to be disclosed in our filings with the SEC or other regulatory authorities, and are not intended to create legal rights or obligations. In addition, historical, current, and forward-looking social, environmental and sustainability-related statements may be based on: standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future.
All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)
For the three months ended March 31,
2026
2025
Revenue from products
$
1,757
$
1,709
Revenue from services
368
360
Revenue
2,125
2,069
Cost of revenue from products
1,057
1,041
Cost of revenue from services
265
260
Cost of revenue
1,322
1,301
Gross profit
803
768
Selling, general and administrative expenses
472
460
Research and development expenses
56
56
Restructuring and asset impairment charges
31
21
Operating income
244
231
Interest expense
(4
)
(8
)
Other non-operating income, net
—
4
Gain/(Loss) on sale of businesses
4
(10
)
Income before taxes
244
217
Income tax expense
(55
)
(50
)
Net income
$
189
$
167
Net loss attributable to non-controlling interests
4
2
Net income attributable to Xylem
$
193
$
169
Earnings per share:
Basic
$
0.79
$
0.69
Diluted
$
0.79
$
0.69
Weighted average number of shares:
Basic
242.8
243.1
Diluted
243.4
243.8
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in millions)
March 31,
2026
December 31,
2025
ASSETS
Current assets:
Cash and cash equivalents
$
808
$
1,479
Receivables, less allowances for discounts, returns and credit losses of $53 and $68 in 2026 and 2025, respectively
1,796
1,759
Inventories
991
983
Prepaid and other current assets
243
244
Assets held for sale
192
176
Total current assets
4,030
4,641
Property, plant and equipment, net
1,151
1,159
Goodwill
8,292
8,332
Other intangible assets, net
2,213
2,272
Other non-current assets
1,268
1,230
Total assets
$
16,954
$
17,634
LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
969
$
1,013
Accrued and other current liabilities
1,182
1,237
Short-term borrowings and current maturities of long-term debt
531
534
Liabilities held for sale
73
72
Total current liabilities
2,755
2,856
Long-term debt
1,407
1,408
Accrued post-retirement benefit obligations
308
317
Deferred income tax liabilities
437
405
Other non-current accrued liabilities
818
899
Total liabilities
5,725
5,885
Redeemable non-controlling interest
249
258
Stockholders’ equity:
Common stock – par value $0.01 per share:
Authorized 750.0 shares, issued 260.3 shares and 259.9 shares in 2026 and 2025, respectively
3
3
Capital in excess of par value
8,772
8,759
Retained earnings
3,794
3,706
Treasury stock – at cost 21.2 shares and 16.3 shares in 2026 and 2025, respectively
(1,368
)
(768
)
Accumulated other comprehensive loss
(229
)
(220
)
Total stockholders’ equity
10,972
11,480
Non-controlling interests
8
11
Total equity
10,980
11,491
Total liabilities, redeemable non-controlling interest, and stockholders’ equity
$
16,954
$
17,634
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions)
For the three months ended March 31,
2026
2025
Operating Activities
Net income
$
189
$
169
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
65
68
Amortization
75
77
Share-based compensation
13
12
Restructuring and asset impairment charges
31
21
(Gain) Loss from sale of businesses
(4
)
10
Other, net
(8
)
11
Payments for restructuring
(37
)
(21
)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables
(58
)
(48
)
Changes in inventories
(18
)
(9
)
Changes in accounts payable
(61
)
(64
)
Changes in long term receivables
(31
)
(32
)
Other, net
(48
)
(161
)
Net Cash – Operating activities
108
33
Investing Activities
Capital expenditures
(90
)
(71
)
Acquisitions of businesses, net of cash acquired
—
(7
)
Proceeds from sale of businesses, net of cash disposed
—
48
Proceeds from the sale of property, plant and equipment
1
5
Cash paid for investments
—
(1
)
Cash paid for asset acquisition
(1
)
—
Cash received from cross-currency swaps
14
12
Other, net
—
(1
)
Net Cash – Investing activities
(76
)
(15
)
Financing Activities
Short-term debt issued, net
—
1
Long-term debt repaid
(4
)
(4
)
Repurchase of common stock
(563
)
(13
)
Proceeds from exercise of employee stock options
—
6
Dividends paid
(106
)
(98
)
Other, net
(10
)
(8
)
Net Cash – Financing activities
(683
)
(116
)
Effect of exchange rate changes on cash
(15
)
25
Increase in cash classified within assets held for sale
(5
)
—
Decrease in cash classified within assets held for sale
—
11
Changes in cash classified within assets held for sale
(5
)
11
Net change in cash and cash equivalents
(671
)
(62
)
Cash and cash equivalents at beginning of year
1,479
1,121
Cash and cash equivalents at end of period
$
808
$
1,059
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest
$
11
$
12
Income taxes (net of refunds received)
$
28
$
37
Xylem Inc. Non-GAAP Measures
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures that we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.
“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA Margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income attributable to Xylem and earnings per share attributable to Xylem, adjusted to exclude restructuring and realignment costs, amortization of acquired intangible assets, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt.
"Free Cash Flow Margin" defined as free cash flow, adjusted (as applicable) for significant cash paid or received for non-operational tax, acquisition or divestiture activities; divided by revenue.
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“Special charges" defined as non-recurring costs incurred by the Company, such as those related to acquisitions and integrations, divestitures and non-cash impairment charges.
“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic ($ Millions)
(As Reported - GAAP)
(As Adjusted - Organic)
(A)
(B)
(C)
(D)
(E)
(F) = B+C+D+E
(G) = F/(A-D)
Change
% Change
Acquisitions
Divestitures
Change
% Change
Orders
Orders
2026 v. 2025
2026 v. 2025
Book-to-Bill
FX Impact
Adj. 2026 v. 2025
Adj. 2026 v. 2025
2026
2025
Quarter Ended March 31
Xylem Inc.
2,228
2,158
70
3
%
105
%
(12
)
5
(70
)
(7
)
0
%
Water Infrastructure
675
626
49
8
%
112
%
(8
)
5
(32
)
14
2
%
Applied Water
512
486
26
5
%
114
%
-
-
(15
)
11
2
%
Measurement and Control Solutions
475
402
73
18
%
94
%
-
-
(11
)
62
15
%
Water Solutions and Services
566
644
(78
)
(12
%)
100
%
(4
)
-
(12
)
(94
)
(15
%)
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic ($ Millions)
(As Reported - GAAP)
(As Adjusted - Organic)
(A)
(B)
(C)
(D)
(E)
(F) = B+C+D+E
(G) = F/(A-D)
Change
% Change
Acquisitions
Divestitures
Change
% Change
Revenue
Revenue
2026 v. 2025
2026 v. 2025
FX Impact
Adj. 2026 v. 2025
Adj. 2026 v. 2025
2026
2025
Quarter Ended March 31
Xylem Inc.
2,125
2,069
56
3
%
(5
)
5
(65
)
(9
)
0
%
Water Infrastructure
603
581
22
4
%
(3
)
5
(29
)
(5
)
(1
%)
Applied Water
448
435
13
3
%
-
-
(14
)
(1
)
0
%
Measurement and Control Solutions
508
490
18
4
%
-
-
(11
)
7
(1
%)
Water Solutions and Services
566
563
3
1
%
(2
)
-
(11
)
(10
)
(2
%)
Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
Q1 2026
Q1 2025
As Reported
Adjustments
Adjusted
As Reported
Adjustments
Adjusted
Total Revenue
2,125
-
2,125
2,069
-
2,069
Operating Income
244
98
a
342
231
94
a
325
Operating Margin
11.5
%
16.1
%
11.2
%
15.7
%
Interest Expense
(4
)
-
(4
)
(8
)
-
(8
)
Other Non-Operating Income (Expense)
-
5
b
5
4
-
4
Gain/(Loss) From Sale of Businesses
4
(4
)
c
-
(10
)
10
c
-
Income before Taxes
244
99
343
217
104
321
Provision for Income Taxes
(55
)
(20
)
d
(75
)
(50
)
(22
)
d
(72
)
Net Income
189
79
268
167
82
249
Net Loss Attributable to Non-controlling Interests
4
-
4
2
-
2
Net Income Attributable to Xylem
193
79
272
169
82
251
Diluted Shares
243.4
243.4
243.8
243.8
Diluted EPS
$
0.79
$
0.33
$
1.12
$
0.69
$
0.34
$
1.03
a
Restructuring & realignment costs: 2026 - $38 million; 2025 - $27 million
Special charges: 2026 - $5 million of acquisition, divestiture & integration costs; 2025 - $8 million of acquisition, divestiture & integration costs and $4 million of intangible asset impairment charges
Purchase accounting intangible amortization: 2026 - $55 million; 2025 - $55 million
b
Other special charges
c
Gain/(Loss) from sale of businesses as per income statement for all periods presented
d
2026 - Net tax impact on pre-tax adjustments (notes a, b and c) of $21 million and $1 million of other tax special expense items; 2025 - Net tax impact on pre-tax adjustments (note a and b) of $22 million
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
2026
Q1
Q2
Q3
Q4
Total
Net Income attributable to Xylem
193
193
Net Income margin
9.1
%
9.1
%
Depreciation
65
65
Amortization
75
75
Interest Expense (Income), net
(4
)
(4
)
Income Tax Expense
55
55
EBITDA
384
384
Share-based Compensation
13
13
Restructuring & Realignment
38
38
Special Charges
10
10
Loss/(Gain) from sale of businesses
(4
)
(4
)
Loss attributable to non-controlling interest
(4
)
(4
)
Adjusted EBITDA
437
437
Revenue
2,125
2,125
Adjusted EBITDA Margin
20.6
%
20.6
%
2025
Q1
Q2
Q3
Q4
Total
Net Income attributable to Xylem
169
226
227
335
957
Net Income margin
8.2
%
9.8
%
10.0
%
14.0
%
10.6
%
Depreciation
68
69
64
66
267
Amortization
77
76
78
77
308
Interest Expense (Income), net
-
3
-
(1
)
2
Income Tax Expense
50
75
71
35
231
EBITDA
364
449
440
512
1,765
Share-based Compensation
12
13
12
16
53
Restructuring & Realignment
27
29
30
45
131
Special Charges
12
13
9
2
36
Loss/(Gain) from sale of businesses
10
-
37
(16
)
31
Loss attributable to non-controlling interest
(2
)
(2
)
(1
)
(2
)
(7
)
Adjusted EBITDA
423
502
527
557
2,009
Revenue
2,069
2,301
2,268
2,397
9,035
Adjusted EBITDA Margin
20.4
%
21.8
%
23.2
%
23.2
%
22.2
%
View source version on businesswire.com: https://www.businesswire.com/news/home/20260427390392/en/
Media
Press Office
+1 (978) 704-5149
PressOffice@xylem.com
Investors
Michael Travers
+1 (724) 772-1597
Michael.Travers@xylem.com
Original: Xylem Reports First Quarter Results
US Market News
4月前
Xylem Reports Fourth Quarter and Full Year 2025 ResultsFebruary 10, 2026 6:55 AM
Business Wire
Fourth-Quarter Highlights
Orders of $2.4 billion, up 9% on a reported basis and 7% organically
Revenue of $2.4 billion, up 6% on a reported basis and 4% organically
Earnings per share of $1.37, up 2%; $1.42 on an adjusted basis, up 20%
Full-Year Highlights
Revenue of $9.0 billion, up 6% on a reported basis and 5% organically
Earnings per share of $3.92, up 7%; $5.08 on an adjusted basis, up 19%
Initiating 2026 full-year revenue guidance of $9.1 to $9.2 billion, up 2% to 4% organically, and adjusted earnings per share of $5.35 to $5.60
Xylem Inc. (NYSE: XYL), a leading global water solutions company dedicated to solving the world’s most challenging water issues, today reported fourth-quarter and full-year 2025 results. The Company’s fourth-quarter revenue of $2.4 billion was driven by strong execution. Fourth-quarter adjusted earnings per share were up 20% driven by productivity and price.
“The team delivered an exceptionally strong fourth quarter, capping a year of solid execution and transformation across Xylem,” said Matthew Pine, Xylem’s CEO. “We achieved record full-year revenue, adjusted EBITDA margin, and adjusted EPS, supported by broad-based demand across our largest end markets. Healthy organic revenue and orders growth gave us solid momentum coming into 2026.”
“Xylem’s transformation continues to strengthen the quality of our earnings and position us for sustainable, profitable growth. In 2026, we expect resilient underlying demand as we sharpen our focus on simplifying the product portfolio to deliver essential technologies that help customers address their biggest water challenges. We remain confident in both our 2026 outlook and our ability to execute against our long-term framework.”
Net income attributable to Xylem for the quarter was $335 million, or $1.37 per share. Net income margin decreased 50 basis points to 14.0 percent. These results are driven by strong operational performance and a reduction in the estimated loss on sale of businesses, partially offset by increased restructuring and realignment costs. Adjusted net income attributable to Xylem was $348 million, or $1.42 per share, which excludes the loss on sale of businesses, purchase accounting intangible amortization, restructuring and realignment costs, and special charges.
Fourth-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 23.2 percent, reflecting a year-over-year increase of 220 basis points. Productivity savings and strong price realization drove the margin expansion, exceeding the impact of inflation, lower volumes, and tariffs.
The Board of Directors of Xylem has declared a first-quarter dividend of $0.43 per share, an increase of 8 percent. The dividend is payable on March 24, 2026, to shareholders of record as of February 24, 2026.
Outlook
Xylem forecasts full-year 2026 revenue of approximately $9.1 to $9.2 billion, up approximately 1 to 3 percent on a reported basis and up approximately 2 to 4 percent on an organic basis.
Full-year 2026 adjusted EBITDA margin is expected to be approximately 22.9 to 23.3 percent, an increase of 70 to 110 basis points from Xylem’s 2025 adjusted results. Full-year free cash flow margin is expected to be approximately 10.2 to 11 percent.
Further 2026 planning assumptions are included in Xylem’s fourth-quarter 2025 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.
Supplemental information on Xylem’s fourth-quarter earnings, as well as definitions of and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.
About Xylem
Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 22,000 employees delivered revenue of $9 billion in 2025, optimizing water and resource management with innovation and expertise. Join us at www.xylem.com and Let’s Solve Water.
Forward-Looking Statements
This press release contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “outlook,” “forecast,” “likely,” “believe,” “target,” “goal,” “objective,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.
Although we believe that expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition, results of operations, and any forward-looking statements are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, interest rates, availability of funding for customers, inflation and governments’ related monetary policy in response, and the strength of the real estate markets, on economic activity and our operations; geopolitical matters, including nationalism, protectionism and anti-global sentiment, volatility involving the U.S. and other governments, ongoing, escalation or outbreak of international conflicts, and regulatory, trade protection, economic and other risks associated with our global sales and operations; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, labor shortages, trade agreements, tariffs, and other trade protection measures, and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents, data breaches, or other disruptions of information technology systems on which we or our customers rely, or involving our connected products and services; lack of availability or delays in receiving parts and raw materials from our supply chain, including semiconductors or other key components; operational disruptions at our facilities or that of third parties upon which we rely; safe and compliant treatment and handling of water, wastewater and hazardous materials; failure to successfully execute large projects, including as respects performance guarantees and customers’ budgets, timelines and safety requirements; our ability to retain, compete for and attract leadership, other key talent and labor; defects, security, warranty and liability claims, and recalls related to our products; uncertainty around productivity, simplification, restructuring and realignment actions and related costs and savings; our ability to execute strategic investments for growth, including acquisitions and divestitures; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on our business and operations due to weather conditions, including the effects of climate change; risks related to our sustainability efforts and related disclosures; fluctuations in foreign currency exchange rates; difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; failure to comply with, or changes in, laws or regulations, pertaining to our business conduct, operations, products and services, including anti-corruption, artificial intelligence, data privacy and security, trade, competition, the environment, climate change and health and safety; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; matters related to intellectual property infringement or expiration of rights; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).
Forward-looking and other statements in this press release regarding our environmental and other sustainability efforts, plans and goals are not an indication that these statements are necessarily material to investors, to our business, operating results, financial condition, outlook, or strategy, to our impacts on sustainability matters or other parties, or are required to be disclosed in our filings with the SEC or other regulatory authorities, and are not intended to create legal rights or obligations. In addition, historical, current, and forward-looking social, environmental and sustainability-related statements may be based on: standards for measuring progress that are still developing; internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
XYLEM INC. AND SUBSIDIARIES
CONSOLIDATED INCOME STATEMENTS (Unaudited)
(In Millions, except per share data)
Year Ended December 31,
2025
2024
2023
Revenue from products
$
7,472
$
7,095
$
6,291
Revenue from services
1,563
1,467
1,073
Revenue
9,035
8,562
7,364
Cost of revenue from products
4,459
4,250
3,817
Cost of revenue from services
1,101
1,100
830
Cost of revenue
5,560
5,350
4,647
Gross profit
3,475
3,212
2,717
Selling, general and administrative expenses
1,923
1,911
1,757
Research and development expenses
226
230
232
Restructuring and asset impairment charges
103
62
76
Operating income
1,223
1,009
652
Interest expense
(29
)
(44
)
(49
)
Gain on remeasurement of previously held equity interest
—
152
—
Other non-operating income, net
18
16
33
Loss on sale of businesses
(31
)
(46
)
(1
)
Income before taxes
1,181
1,087
635
Income tax expense
(231
)
(197
)
(26
)
Net income
$
950
$
890
$
609
Net loss attributable to non-controlling interests
7
—
—
Net income attributable to Xylem
$
957
$
890
$
609
Earnings per share:
Basic
$
3.93
$
3.67
$
2.81
Diluted
$
3.92
$
3.65
$
2.79
Weighted average number of shares:
Basic
243.4
242.6
217.0
Diluted
244.0
243.5
218.2
XYLEM INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (Unaudited)
(In Millions)
December 31,
2025
2024
ASSETS
Current assets:
Cash and cash equivalents
$
1,479
$
1,121
Receivables, less allowances for discounts, returns and credit losses of $68 and $59 in 2025 and 2024, respectively
1,759
1,668
Inventories
983
996
Prepaid and other current assets
244
236
Assets held for sale
176
77
Total current assets
4,641
4,098
Property, plant and equipment, net
1,159
1,152
Goodwill
8,332
7,980
Other intangible assets, net
2,272
2,379
Other non-current assets
1,230
884
Total assets
$
17,634
$
16,493
LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST, AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
1,013
$
1,006
Accrued and other current liabilities
1,237
1,271
Short-term borrowings and current maturities of long-term debt
534
38
Liabilities held for sale
72
21
Total current liabilities
2,856
2,336
Long-term debt, net
1,408
1,978
Accrued post-retirement benefit obligations
317
304
Deferred income tax liabilities
405
497
Other non-current accrued liabilities
899
496
Total liabilities
5,885
5,611
Redeemable non-controlling interest
258
235
Stockholders’ equity:
Common stock — par value $0.01 per share:
Authorized 750.0 shares, issued 259.9 and 259.2 shares in 2025 and 2024, respectively
3
3
Capital in excess of par value
8,759
8,687
Retained earnings
3,706
3,140
Treasury stock – at cost 16.3 shares and 16.2 shares in 2025 and 2024, respectively
(768
)
(753
)
Accumulated other comprehensive loss
(220
)
(435
)
Total stockholders’ equity
11,480
10,642
Non-controlling interest
11
5
Total equity
11,491
10,647
Total liabilities, redeemable non-controlling interest, and stockholders’ equity
$
17,634
$
16,493
XYLEM INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (In Millions) (Unaudited)
Year Ended December 31,
2025
2024
2023
Operating Activities
Net income
$
950
$
890
$
609
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
267
258
193
Amortization
308
304
243
Deferred income taxes
(35
)
(36
)
(79
)
Share-based compensation
53
56
60
Restructuring and asset impairment charges
103
62
76
Loss from sale of businesses
31
46
1
Gain on remeasurement of previously held equity interest
—
(152
)
—
Other, net
5
4
—
Payments for restructuring
(82
)
(32
)
(30
)
Contributions to post-retirement benefit plans
(26
)
(25
)
(25
)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables
(55
)
(107
)
(87
)
Changes in inventories
23
(41
)
41
Changes in accounts payable
(22
)
64
22
Changes in accrued liabilities
(69
)
17
(4
)
Changes in accrued and deferred taxes
—
14
(109
)
Changes in long term receivables
(146
)
(37
)
1
Net changes in other assets and liabilities
(64
)
(22
)
(75
)
Net Cash — Operating activities
1,241
1,263
837
Investing Activities
Capital expenditures
(331
)
(321
)
(271
)
Proceeds from the sale of property, plant and equipment
17
4
1
Acquisitions of businesses, net of cash acquired
(163
)
(193
)
(476
)
Proceeds from sale of businesses, net of cash disposed
49
11
105
Cash received from investments
8
6
1
Cash paid for investments
(42
)
(11
)
(1
)
Cash paid for equity investments
(7
)
(6
)
(57
)
Cash received from interest rate swaps
—
—
38
Cash received from cross-currency swaps
35
29
28
Cash paid for asset acquisition
(37
)
—
—
Other, net
—
(1
)
4
Net Cash — Investing activities
(471
)
(482
)
(628
)
Financing Activities
Short-term debt issued, net
1
—
—
Short-term debt repaid
—
(268
)
—
Long-term debt issued, net
—
1
278
Long-term debt repaid, net
(82
)
(17
)
(160
)
Repurchase of common stock
(15
)
(20
)
(25
)
Proceeds from exercise of employee stock options
20
67
62
Dividends paid
(391
)
(350
)
(299
)
Other, net
(34
)
(28
)
(13
)
Net Cash — Financing activities
(501
)
(615
)
(157
)
Effect of exchange rate changes on cash
90
(53
)
23
Increase in cash classified within assets held for sale
(12
)
(11
)
—
Decrease in cash classified within assets held for sale
11
—
—
Cash classified within assets held for sale
(1
)
(11
)
—
Net change in cash and cash equivalents
358
102
75
Cash and cash equivalents at beginning of year
1,121
1,019
944
Cash and cash equivalents at end of year
$
1,479
$
1,121
$
1,019
Supplemental disclosure of cash flow information:
Cash paid during the year for:
Interest
$
61
$
67
$
69
Income taxes (net of refunds received)
$
267
$
219
$
211
Xylem Inc. Non-GAAP Measures
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures that we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.
“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA Margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income attributable to Xylem and earnings per share attributable to Xylem, adjusted to exclude restructuring and realignment costs, amortization of acquired intangible assets, gain or loss from sale of businesses, gain on remeasurement of previously held equity interest, special charges and tax-related special items, as applicable.
"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt.
"Free Cash Flow Margin" defined as free cash flow, adjusted (as applicable) for significant cash paid or received for non-operational tax, acquisition or divestiture activities; divided by revenue.
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“Special charges" defined as non-recurring costs incurred by the Company, such as those related to acquisitions and integrations, divestitures and non-cash impairment charges.
“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic and Constant Currency Orders ($ Millions)
(As Reported)
(As Adjusted - Organic)
Constant
Currency
(A)
(B)
(C)
(D)
(E) = B+C+D
(F) = E/A
(G) = (E - C) / A
Change
% Change
Acquisitions /
Divestitures
Change
% Change
Orders
Orders
2025 v. 2024
2025 v. 2024
Book-to-Bill
FX Impact
Adj. 2025 v. 2024
Adj. 2025 v. 2024
2025
2024
Year Ended December 31
Xylem Inc.
8,904
8,730
174
2
%
99
%
30
(65
)
139
2
%
1
%
Water Infrastructure
2,672
2,727
(55
)
(2
%)
101
%
60
(35
)
(30
)
(1
%)
(3
%)
Applied Water
1,893
1,824
69
4
%
102
%
-
(15
)
54
3
%
3
%
Measurement and Control Solutions
1,873
1,672
201
12
%
90
%
(30
)
(14
)
157
9
%
11
%
Water Solutions and Services
2,466
2,507
(41
)
(2
%)
100
%
-
(1
)
(42
)
(2
%)
(2
%)
Quarter Ended December 31
Xylem Inc.
2,391
2,196
195
9
%
100
%
10
(45
)
160
7
%
7
%
Water Infrastructure
691
691
-
0
%
92
%
15
(22
)
(7
)
(1
%)
(3
%)
Applied Water
474
442
32
7
%
100
%
-
(10
)
22
5
%
5
%
Measurement and Control Solutions
588
473
115
24
%
110
%
(5
)
(7
)
103
22
%
23
%
Water Solutions and Services
638
590
48
8
%
100
%
-
(6
)
42
7
%
7
%
Quarter Ended September 30
Xylem Inc.
2,181
2,201
(20
)
(1
%)
96
%
2
(27
)
(45
)
(2
%)
(2
%)
Water Infrastructure
683
700
(17
)
(2
%)
104
%
15
(13
)
(15
)
(2
%)
(4
%)
Applied Water
445
437
8
2
%
98
%
-
(6
)
2
-
-
Measurement and Control Solutions
446
386
60
16
%
85
%
(13
)
(5
)
42
11
%
14
%
Water Solutions and Services
607
678
(71
)
(10
%)
96
%
-
(3
)
(74
)
(11
%)
(11
%)
Quarter Ended June 30
Xylem Inc.
2,174
2,087
87
4
%
94
%
13
(23
)
77
4
%
3
%
Water Infrastructure
672
690
(18
)
(3
%)
103
%
16
(12
)
(14
)
(2
%)
(4
%)
Applied Water
488
465
23
5
%
101
%
-
(5
)
18
4
%
4
%
Measurement and Control Solutions
437
384
53
14
%
81
%
(3
)
(5
)
45
12
%
13
%
Water Solutions and Services
577
548
29
5
%
92
%
-
(1
)
28
5
%
5
%
Quarter Ended March 31
Xylem Inc.
2,158
2,246
(88
)
(4
%)
104
%
5
30
(53
)
(2
%)
(3
%)
Water Infrastructure
626
646
(20
)
(3
%)
108
%
14
12
6
1
%
(1
%)
Applied Water
486
480
6
1
%
112
%
-
6
12
3
%
3
%
Measurement and Control Solutions
402
429
(27
)
(6
%)
82
%
(9
)
3
(33
)
(8
%)
(6
%)
Water Solutions and Services
644
691
(47
)
(7
%)
114
%
-
9
(38
)
(5
%)
(5
%)
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic and Constant Currency Revenue ($ Millions)
(As Reported - GAAP)
(As Adjusted - Organic)
Constant Currency
(A)
(B)
(C)
(D)
(E) = B+C+D
(F) = E/A
(G) = (E - C) / A
Change
% Change
Acquisitions /
Divestitures
Change
% Change
Revenue
Revenue
2025 v. 2024
2025 v. 2024
FX Impact
Adj. 2025 v. 2024
Adj. 2025 v. 2024
2025
2024
Year Ended December 31
Xylem Inc.
9,035
8,562
473
6
%
17
(71
)
419
5
%
5
%
Water Infrastructure
2,636
2,555
81
3
%
48
(41
)
88
3
%
2
%
Applied Water
1,849
1,793
56
3
%
-
(14
)
42
2
%
2
%
Measurement and Control Solutions
2,086
1,871
215
11
%
(30
)
(13
)
172
9
%
11
%
Water Solutions and Services
2,464
2,343
121
5
%
(1
)
(3
)
117
5
%
5
%
Quarter Ended December 31
Xylem Inc.
2,397
2,256
141
6
%
(6
)
(48
)
87
4
%
4
%
Water Infrastructure
749
727
22
3
%
4
(26
)
-
-
(1
%)
Applied Water
475
454
21
5
%
-
(9
)
12
3
%
3
%
Measurement and Control Solutions
534
469
65
14
%
(9
)
(7
)
49
10
%
12
%
Water Solutions and Services
639
606
33
5
%
(1
)
(6
)
26
4
%
4
%
Quarter Ended September 30
Xylem Inc.
2,268
2,104
164
8
%
7
(26
)
145
7
%
7
%
Water Infrastructure
656
623
33
5
%
15
(14
)
34
5
%
3
%
Applied Water
456
447
9
2
%
-
(5
)
4
1
%
1
%
Measurement and Control Solutions
522
458
64
14
%
(8
)
(6
)
50
11
%
13
%
Water Solutions and Services
634
576
58
10
%
-
(1
)
57
10
%
10
%
Quarter Ended June 30
Xylem Inc.
2,301
2,169
132
6
%
11
(23
)
120
6
%
5
%
Water Infrastructure
650
631
19
3
%
19
(12
)
26
4
%
1
%
Applied Water
483
456
27
6
%
-
(6
)
21
5
%
5
%
Measurement and Control Solutions
540
482
58
12
%
(8
)
(4
)
46
10
%
11
%
Water Solutions and Services
628
600
28
5
%
-
(1
)
27
5
%
5
%
Quarter Ended March 31
Xylem Inc.
2,069
2,033
36
2
%
5
26
67
3
%
3
%
Water Infrastructure
581
574
7
1
%
10
11
28
5
%
3
%
Applied Water
435
436
(1
)
(0
%)
-
6
5
1
%
1
%
Measurement and Control Solutions
490
462
28
6
%
(5
)
4
27
6
%
7
%
Water Solutions and Services
563
561
2
0
%
-
5
7
1
%
1
%
Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
Q4 2025
Q4 2024
As Reported
Adjustments
Adjusted
As Reported
Adjustments
Adjusted
Total Revenue
2,397
-
2,397
2,256
-
2,256
Operating Income
353
103
a
456
267
110
a
377
Operating Margin
14.7
%
19.0
%
11.8
%
16.7
%
Interest Expense
(6
)
-
(6
)
(9
)
-
(9
)
Other Non-Operating Income (Expense)
5
-
5
5
-
5
Gain on remeasurement of previously held equity interest
-
-
-
152
(152
)
b
-
Gain/(Loss) From Sale of Business
16
(16
)
c
-
(40
)
40
c
-
Income before Taxes
368
87
455
375
(2
)
373
Provision for Income Taxes
(35
)
(74
)
d
(109
)
(49
)
(37
)
d
(86
)
Net Income
333
13
346
326
(39
)
287
Net Loss Attributable to Non-controlling Interests
2
-
2
-
-
-
Net Income Attributable to Xylem
335
13
348
326
(39
)
287
Diluted Shares
244.2
244.2
243.8
243.8
Diluted EPS
$
1.37
$
0.05
$
1.42
$
1.34
($
0.16
)
$
1.18
Q4 YTD 2025
Q4 YTD 2024
As Reported
Adjustments
Adjusted
As Reported
Adjustments
Adjusted
Total Revenue
9,035
-
9,035
8,562
-
8,562
Operating Income
1,223
389
a
1,612
1,009
364
a
1,373
Operating Margin
13.5
%
17.8
%
11.8
%
16.0
%
Interest Expense
(29
)
-
(29
)
(44
)
-
(44
)
Other Non-Operating Income (Expense)
18
-
18
16
-
16
Gain on remeasurement of previously held equity interest
-
-
-
152
(152
)
b
Gain/(Loss) From Sale of Business
(31
)
31
c
-
(46
)
46
c
-
Income before Taxes
1,181
420
1,601
1,087
258
1,345
Provision for Income Taxes
(231
)
(137
)
d
(368
)
(197
)
(107
)
d
(304
)
Income Attributable to Minority Interest
-
-
-
Net Income
950
283
1,233
890
151
1,041
Net Loss Attributable to Non-controlling Interests
7
-
7
-
-
-
Net Income Attributable to Xylem
957
283
1,240
890
151
1,041
Diluted Shares
244.0
244.0
243.5
243.5
Diluted EPS
$
3.92
$
1.16
$
5.08
$
3.65
$
0.62
$
4.27
a
Quarter-to-date:
Restructuring & realignment costs: 2025 - $46 million and 2024 - $36 million
Special charges: 2025 - $2 million of acquisition, divestiture & integration costs; 2024 - $15 million of acquisition & integration costs and $6 million of other special charges
Purchase accounting intangible amortization: 2025 - $55 million and 2024 - $53 million
Year-to-date:
Restructuring & realignment costs: 2025 - $133 million and 2024 - $91 million
Special charges: 2025 - $28 million of acquisition, divestiture & integration costs and $8 million of intangible asset impairment charges; 2024 - $50 million of acquisition & integration related costs and $7 million of intangible asset impairment charges
Purchase accounting intangible amortization: 2025 - $220 million and 2024 - $216 million
b
Gain on joint venture remeasurement as per income statement
c
Gain/(Loss) from sale of business as per income statement for all periods presented
d
Quarter-to-date: 2025 - Net tax impact on pre-tax adjustments (notes a and c) of $16 million and $58 million of other tax special benefit items, primarily deferred tax benefits from internal reorganizations; 2024 - Net tax impact on pre-tax adjustments (notes a, b and c) of $29 million and other tax special benefit items of $8 million
Year-to-date: 2025 - Net tax impact on pre-tax adjustments (notes a and c) of $85 million and other tax special benefit items of $52 million, primarily deferred tax benefits from internal reorganizations; 2024 - Net tax impact on pre-tax adjustments (notes a, b and c) of $88 million and other tax special benefit items of $19 million
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
2025
Q1
Q2
Q3
Q4
Total
Net Income attributable to Xylem
169
226
227
335
957
Net Income margin
8.2
%
9.8
%
10.0
%
14.0
%
10.6
%
Depreciation
68
69
64
66
267
Amortization
77
76
78
77
308
Interest Expense (Income), net
-
3
-
(1
)
2
Income Tax Expense
50
75
71
35
231
EBITDA
364
449
440
512
1,765
Share-based Compensation
12
13
12
16
53
Restructuring & Realignment
27
29
30
45
131
Special Charges
12
13
9
2
36
Loss/(Gain) from sale of businesses
10
-
37
(16
)
31
Loss attributable to non-controlling interest
(2
)
(2
)
(1
)
(2
)
(7
)
Adjusted EBITDA
423
502
527
557
2,009
Revenue
2,069
2,301
2,268
2,397
9,035
Adjusted EBITDA Margin
20.4
%
21.8
%
23.2
%
23.2
%
22.2
%
2024
Q1
Q2
Q3
Q4
Total
Net Income
153
194
217
326
890
Net Income margin
7.5
%
8.9
%
10.3
%
14.5
%
10.4
%
Depreciation
61
62
68
67
258
Amortization
73
83
73
75
304
Interest Expense (Income), net
7
6
5
(2
)
16
Income Tax Expense
43
53
52
49
197
EBITDA
337
398
415
515
1,665
Share-based Compensation
18
13
12
13
56
Restructuring & Realignment
15
29
11
36
91
Special Charges
16
13
7
21
57
Gain on joint venture remeasurement
-
-
-
(152
)
(152
)
Loss/(Gain) from sale of businesses
5
(1
)
2
40
46
Adjusted EBITDA
391
452
447
473
1,763
Revenue
2,033
2,169
2,104
2,256
8,562
Adjusted EBITDA Margin
19.2
%
20.8
%
21.2
%
21.0
%
20.6
%
View source version on businesswire.com: https://www.businesswire.com/news/home/20260209169970/en/
Media
Houston Spencer +1 (914) 240-3046
Houston.Spencer@xylem.com
Investors
Keith Buettner +1 (724) 772-1531
Keith.Buettner@xylem.com
Original: Xylem Reports Fourth Quarter and Full Year 2025 Results
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
iHub News
4月前
Monksdream
2年前
kohut
14年前
Penny Roger$
14年前
メールアドレスで登録
